| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |